Reify Health logo

Reify Health

Challenger

Reify Health raised $220M Series D at $4.8B valuation; OneStudyTeam and Care Access accelerate clinical trial site operations and decentralized enrollment; $407M total raised to bridge diversity gap in trials.

Best for: Clinical Trial Operations & Enrollment
54
AI Score
Grade C
AI Visibility Score (Beta)
Life Sciences & BioTechClinical Trial Operations & EnrollmentWebsiteUpdated October 2026

Company Overview

About Reify Health

Reify Health is a clinical trial acceleration company whose two platform arms — OneStudyTeam and Care Access — address the two biggest friction points in clinical research: site operations efficiency and patient enrollment reach. OneStudyTeam provides workflow software that automates the administrative burden on clinical research sites, enabling faster startup, better sponsor-site collaboration, and compliant data capture throughout trial execution. Care Access operates a decentralized clinical trial infrastructure that brings research directly to patients in underserved communities, expanding the diversity and geographic reach of clinical study populations.

Business Model & Competitive Advantage

Founded in 2017 and headquartered in Boston, Massachusetts, Reify Health has raised over $407 million in total funding, including a $220 million Series D in April 2022 co-led by Altimeter Capital and Coatue at a valuation of $4.8 billion. Other investors include ICONIQ Growth, Adams Street Partners, Dragoneer Investment Group, and Battery Ventures. The company's two back-to-back $220 million rounds (Series C and Series D within a single year) reflected strong investor conviction in the critical infrastructure role Reify plays in accelerating drug development timelines — a market where each day of delay in a Phase III trial can cost a pharmaceutical sponsor millions of dollars.

Competitive Landscape 2025–2026

Reify Health's diversity and inclusion initiative, BRIDGE, targets the persistent underrepresentation of minority groups in clinical trials — a structural problem that limits the generalizability of drug data and has historically disadvantaged non-white patient populations in pharmaceutical development. By embedding Care Access's community-based research sites and decentralized trial capabilities alongside OneStudyTeam's operational software, Reify provides a comprehensive solution that spans from study design through patient enrollment and site management, making it a strategic partner for major pharmaceutical companies and contract research organizations seeking faster and more representative trial execution.

Founded
2017
Headquarters
Boston, Massachusetts
Curated content • Fact-checked and verified

Key Differentiators

Strong Challenger

Reify Health is an established challenger with significant market presence and competitive offerings in Life Sciences & BioTech.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

54
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Emulate logo

Emulate

Life Sciences & BioTech
HealthtechB2bEnterpriseAi PoweredHardwarePlatformStartupScaleupGlobalNorth America

Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m

ConcertAI logo

ConcertAI

Life Sciences & BioTech
HealthtechAi PoweredAnalyticsB2bSaasEnterpriseData WarehousePlatformUnicorn

ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult

DNAnexus logo

DNAnexus

Life Sciences & BioTech
B2bSaasHealthtechCloud NativeAnalyticsEnterprisePlatformGlobalAi PoweredInfrastructure

DNAnexus is the category-defining cloud platform for precision health data management, analysis, and collaboration. Founded in 2009 and headquartered in Mountain View, California, DNAnexus provides a

Tempus logo

Tempus

Life Sciences & BioTech
HealthtechB2bAi PoweredAnalyticsPlatformPublicSaasTechnologyNorth America

Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o

Schrödinger logo

Schrödinger

Life Sciences & BioTech
B2bGlobalPublicEnterpriseHealthtechAi PoweredSaasPlatformAnalytics

Schrödinger was founded in 1990 by Richard Friesner and David Pearlman in New York City, building physics-based computational methods for molecular simulation. For over 30 years the company has develo

Florence Healthcare logo

Florence Healthcare

Life Sciences & BioTech
B2bSaasHealthtechEnterprisePlatformGlobalCloud NativeAnalytics

Florence Healthcare is the dominant software platform for clinical trial site enablement, providing digital tools that connect trial sites, sponsors, and contract research organizations (CROs) to stre

Compare Reify Health with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Reify Health

Claim This Profile

Are you from Reify Health? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Reify Health Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Reify Health vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →